Fifth Third Bancorp Lowers Stock Position in Stevanato Group S.p.A. $STVN

Fifth Third Bancorp lessened its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 20.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,965 shares of the company’s stock after selling 1,008 shares during the quarter. Fifth Third Bancorp’s holdings in Stevanato Group were worth $97,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in STVN. Yarbrough Capital LLC acquired a new stake in shares of Stevanato Group in the first quarter valued at about $329,000. Conestoga Capital Advisors LLC lifted its stake in shares of Stevanato Group by 1.3% in the first quarter. Conestoga Capital Advisors LLC now owns 8,189,926 shares of the company’s stock valued at $167,238,000 after purchasing an additional 106,930 shares during the period. Oppenheimer Asset Management Inc. lifted its stake in shares of Stevanato Group by 7.8% in the first quarter. Oppenheimer Asset Management Inc. now owns 13,878 shares of the company’s stock valued at $283,000 after purchasing an additional 1,004 shares during the period. Cooper Investors PTY Ltd. lifted its stake in shares of Stevanato Group by 22.4% in the first quarter. Cooper Investors PTY Ltd. now owns 137,605 shares of the company’s stock valued at $2,810,000 after purchasing an additional 25,221 shares during the period. Finally, Bessemer Group Inc. lifted its stake in shares of Stevanato Group by 14,623.3% in the first quarter. Bessemer Group Inc. now owns 13,251 shares of the company’s stock valued at $270,000 after purchasing an additional 13,161 shares during the period.

Stevanato Group Stock Performance

Shares of STVN opened at €26.36 on Thursday. The company has a current ratio of 1.79, a quick ratio of 1.22 and a debt-to-equity ratio of 0.25. The stock has a market cap of $7.98 billion, a P/E ratio of 48.81, a PEG ratio of 2.43 and a beta of 0.57. The company has a 50-day moving average of €24.57 and a two-hundred day moving average of €23.42. Stevanato Group S.p.A. has a 12-month low of €17.12 and a 12-month high of €28.00.

Wall Street Analysts Forecast Growth

Separately, William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research note on Monday, June 30th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.